87 related articles for article (PubMed ID: 23600498)
1. Structure-based peptide mimicry of tumor-associated antigens.
Ohtaki A; Kieber-Emmons T; Murali R
Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):1-5. PubMed ID: 23600498
[TBL] [Abstract][Full Text] [Related]
2. In silico design of discontinuous peptides representative of B and T-cell epitopes from HER2-ECD as potential novel cancer peptide vaccines.
Manijeh M; Mehrnaz K; Violaine M; Hassan M; Abbas J; Mohammad R
Asian Pac J Cancer Prev; 2013; 14(10):5973-81. PubMed ID: 24289611
[TBL] [Abstract][Full Text] [Related]
3. In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer.
Baloria U; Akhoon BA; Gupta SK; Sharma S; Verma V
Amino Acids; 2012 Apr; 42(4):1349-60. PubMed ID: 21229277
[TBL] [Abstract][Full Text] [Related]
4. Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens.
Luo P; Agadjanyan M; Qiu J; Westerink MA; Steplewski Z; Kieber-Emmons T
Mol Immunol; 1998 Sep; 35(13):865-79. PubMed ID: 9839555
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of new HER2 peptide vaccination based on B cell epitope.
Miyako H; Kametani Y; Katano I; Ito R; Tsuda B; Furukawa A; Saito Y; Ishikawa D; Ogino K; Sasaki S; Imai K; Habu S; Makuuchi H; Tokuda Y
Anticancer Res; 2011 Oct; 31(10):3361-8. PubMed ID: 21965747
[TBL] [Abstract][Full Text] [Related]
6. Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines.
Wiedermann U; Davis AB; Zielinski CC
Breast Cancer Res Treat; 2013 Feb; 138(1):1-12. PubMed ID: 23340862
[TBL] [Abstract][Full Text] [Related]
7. Peptide mimics of a carbohydrate‑associated epitope expressed by cancer cells: Identification of vaccine candidates.
Wen L; Yang S; Zhu P; Yu Y; Qiu X; Fu N; Liu Y
Mol Med Rep; 2016 Dec; 14(6):5237-5244. PubMed ID: 27779668
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody.
Murali R; Kieber-Emmons T
J Mol Recognit; 1997; 10(6):269-76. PubMed ID: 9770651
[TBL] [Abstract][Full Text] [Related]
9. [Immunogenicity of phage-displayed tumor antigen-mimic peptide].
Xu L; Xu H; Ma F
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):187-9. PubMed ID: 11783081
[TBL] [Abstract][Full Text] [Related]
10. Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines.
Qiu J; Luo P; Wasmund K; Steplewski Z; Kieber-Emmons T
Hybridoma; 1999 Feb; 18(1):103-12. PubMed ID: 10211797
[TBL] [Abstract][Full Text] [Related]
11. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Heimburg-Molinaro J; Almogren A; Morey S; Glinskii OV; Roy R; Wilding GE; Cheng RP; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2009 Aug; 11(8):780-92. PubMed ID: 19649208
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
13. Mimotope vaccines: epitope mimics induce anti-cancer antibodies.
Riemer AB; Jensen-Jarolim E
Immunol Lett; 2007 Oct; 113(1):1-5. PubMed ID: 17825923
[TBL] [Abstract][Full Text] [Related]
14. Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.
Douat-Casassus C; Marchand-Geneste N; Diez E; Gervois N; Jotereau F; Quideau S
J Med Chem; 2007 Apr; 50(7):1598-609. PubMed ID: 17328535
[TBL] [Abstract][Full Text] [Related]
15. Composite peptide-based vaccines for cancer immunotherapy (Review).
Yang J; Zhang Q; Li K; Yin H; Zheng JN
Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
[TBL] [Abstract][Full Text] [Related]
16. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
17. Applications of peptide mimetics in cancer.
Apostolopoulos V; Matsoukas J; Plebanski M; Mavromoustakos T
Curr Med Chem; 2002 Feb; 9(4):411-20. PubMed ID: 11945117
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses.
Kieber-Emmons T; Luo P; Qiu J; Chang TY; O I; Blaszczyk-Thurin M; Steplewski Z
Nat Biotechnol; 1999 Jul; 17(7):660-5. PubMed ID: 10404158
[TBL] [Abstract][Full Text] [Related]
19. Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.
Wang X; Luo W; Foon KA; Ferrone S
Cancer Chemother Biol Response Modif; 2001; 19():309-26. PubMed ID: 11686020
[No Abstract] [Full Text] [Related]
20. Predicted B-cell epitopes of HER-2 oncoprotein by a bioinformatics method: a clue for breast cancer vaccine development.
Wiwanitkit V
Asian Pac J Cancer Prev; 2007; 8(1):137-8. PubMed ID: 17477789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]